Not rendering correctly? View this email as a web page here.

Dear colleague,

As a responsible organisation representing medical oncologists and other professionals, it is ESMO’s duty to keep you informed about policy and regulatory issues in oncology.

With the goal of setting out minimum standards for transparency in the healthcare sector, the European Federation of Pharmaceutical Industries and Associations (EFPIA) and its members in 33 European countries have recently agreed to implement the ‘EFPIA Code on Transfers of Value from Pharmaceutical Companies to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs)’ - the EFPIA Disclosure Code.

Data collection will start on 1 January 2015. What this means for organisations like ESMO, and individual healthcare professionals, is that depending on the laws in each individual country, details of payments and transfers of value will be publicly disclosed, annually and for duration of 3 years, on company websites or national government or industry association platforms. The first disclosure will be in 2016 for the year 2015.

As a service to the oncology community, ESMO has posted the most relevant information on our website under EFPIA Disclosure Code, and will continue updating this section in the coming months. I recommend that you take the time to read the Disclosure Code yourself, by visiting the EFPIA website. I encourage you to familiarise yourself with how this Code will be implemented and regulated in your country and share the information with your colleagues.

We will continue to keep you up-to-date on important European issues affecting your daily practice and profession and we will keep engaging with EU authorities and all relevant European stakeholders on behalf of our members.

Sincerely,

Rolf A. Stahel
ESMO President 2014-2015